Occludin and Zonulin in Attention-deficit/Hyperactivity Disorder
NCT ID: NCT05502471
Last Updated: 2022-08-16
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
79 participants
INTERVENTIONAL
2021-01-01
2021-06-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Motor Performance in Children With Attention Deficit Hyperactivity Disorder
NCT05897437
Neurofeedback and Computerized Cognitive Training in Different Settings for Children and Adolescents With ADHD
NCT02358941
Effect Of Methylphenidate On Balance In Children With Attention Deficit Hyperactivity Disorder
NCT05522478
Neurocognitive Exercise Program for Children With Attention Deficit and Hyperactivity Disorder
NCT04707040
A Systematic Study of Assessment of Attention-Deficit/Hyperactivity Disorder (ADHD)
NCT05588713
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
DIAGNOSTIC
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
ADHD
Children with ADHD
Zonulin
Serum zonulin level
Occludin
Serum occludin level
Control
Children without any psychiatric disorder
Zonulin
Serum zonulin level
Occludin
Serum occludin level
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Zonulin
Serum zonulin level
Occludin
Serum occludin level
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* (b) no prior psychotropic treatment for ADHD or any psychiatric disorder
* (c) age 6-12 years.
Exclusion Criteria
* (b) any special diet history within the past year
* (c) use of corticosteroids or regular intake of medication in the last 6 months,
* (d) body mass index (BMI) \[kg/m2\] \> 30),
* (e) cognitive deficits by developmental history
6 Years
12 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Ataturk University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Hicran Dogru
MD
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Hicran Dogru, MD
Role: PRINCIPAL_INVESTIGATOR
Ataturk University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Ataturk University Hospital
Erzurum, , Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
025
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.